Chargement en cours...
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease
BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...
Enregistré dans:
| Publié dans: | Brain Behav |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043698/ https://ncbi.nlm.nih.gov/pubmed/29856137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|